Market Overview

Benzinga's Top #PreMarket Losers

Benzinga's Top Downgrades
UBS Downgrades Catamaran To Neutral
Market Panic Has Created 'Compelling' Opportunities In Biotech
Piper Jaffray Goes Overweight Sarepta, Expects FDA To Accept Next Key Drug Filing

Catamaran (NASDAQ: CTRX) shares fell 9.27% to $47.00 in the pre-market trading after the company reported Q4 results.

Sarepta Therapeutics (NASDAQ: SRPT) dipped 4.89% to $28.01 after the company reported weaker-than-expected results.

Magic Software Enterprises (NASDAQ: MGIC) shares dropped 2.19% to $9.39 in pre-market trading after rising 6.31% on Wednesday.

InterMune (NASDAQ: ITMN) dipped 2.08% to $31.51 in the pre-market session after dropping 14.87% on Wednesday.

Posted-In: PreMarket LosersNews Movers & Shakers Pre-Market Outlook Markets


Related Articles (ITMN + CTRX)

Get Benzinga's Newsletters